Jupiter Hospitals Q1 results, new CFO, subsidiary acquires Sulcus
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts less than Nifty Microcap 250 and 2.7 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jupiter Life Line Hospitals announced Q1 FY27 (June 2026) results. Standalone revenue was Rs 3,284.85 million with net profit of Rs 623.36 million. Consolidated revenue was Rs 4,109.83 million. Board appointed Mr. Harshad Purani as CFO and KMP from July 31, 2026. He has been with the company since 2007. Subsidiary Jupiter Hospital Pharmacy acquired 100 percent of Sulcus Private Limited for Rs 3.78 crore to set up IV fluids and pharmaceutical manufacturing facility near Ujjain.
Solid Q1 results. New CFO is an internal appointment ensuring continuity. Subsidiary acquisition sets up backward integration for pharmacy operations.